Mood Disorders
Clinical research in mild to moderate major depressive disorder focuses on symptom relief and changes in depressive severity, with attention to Montgomery-Åsberg Depression Rating Scale outcomes, response, and remission.
- Major depressive disorder
- Depressive symptom severity
- Clinical response and remission
The sponsor’s work in this area is centered on treatment options for patients with mild depressive presentations.
Functional Gastrointestinal Disorders
Research activity in functional gastrointestinal disorders examines symptom burden, tolerability, quality of life, and treatment satisfaction, alongside measures related to gut permeability.
- Functional dyspepsia
- Gastrointestinal symptom control
- Quality of life
This area reflects a therapeutic interest in digestive disorders with persistent, non-structural symptoms.
Post-COVID Cognitive Impairment
Trials in cognitive impairment associated with post-COVID-19 syndrome assess objective cognitive outcomes and safety in participants affected by persistent neurocognitive symptoms after infection.
- Post-COVID-19 syndrome
- Cognitive performance
- Neurocognitive recovery
The sponsor is involved in research addressing lingering cognitive effects linked to COVID-19.
Healthy Volunteer Studies
Studies in healthy volunteers support evaluation of pharmacokinetics, bioequivalence, and food-related effects for herbal medicinal products and related formulations.
- Pharmacokinetics
- Bioequivalence
- Food effect studies
This research domain is linked to the sponsor’s development of standardized products used across psychiatric, gastrointestinal, and cognitive indications.
